William Blair Has Positive Forecast for LFST FY2024 Earnings

LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) - Equities research analysts at William Blair raised their FY2024 earnings per share (EPS) estimates for LifeStance Health Group in a research report issued to clients and investors on Thursday, November 7th. William Blair analyst R. Daniels now forecasts that the company will earn ($0.17) per share for the year, up from their prior estimate of ($0.26). The consensus estimate for LifeStance Health Group's current full-year earnings is ($0.22) per share. William Blair also issued estimates for LifeStance Health Group's Q4 2024 earnings at ($0.03) EPS.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.67%. The business had revenue of $312.70 million during the quarter, compared to analysts' expectations of $302.25 million. During the same quarter in the prior year, the company posted ($0.17) EPS. The firm's revenue for the quarter was up 18.9% compared to the same quarter last year.

LFST has been the subject of a number of other research reports. UBS Group decreased their target price on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating for the company in a report on Thursday, August 15th. Barclays raised their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a research report on Monday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $8.42.

LifeStance Health Group Trading Up 0.4 %

Shares of NASDAQ LFST traded up $0.03 during trading hours on Monday, hitting $7.39. The company's stock had a trading volume of 2,020,173 shares, compared to its average volume of 1,506,957. The business has a 50-day simple moving average of $6.92 and a 200-day simple moving average of $6.21. The stock has a market cap of $2.83 billion, a price-to-earnings ratio of -27.73 and a beta of 1.24. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.22 and a current ratio of 1.22. LifeStance Health Group has a 12 month low of $4.64 and a 12 month high of $9.20.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of LFST. CIBC Asset Management Inc purchased a new position in LifeStance Health Group in the 2nd quarter worth approximately $53,000. Bessemer Group Inc. raised its position in LifeStance Health Group by 43.4% in the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company's stock worth $56,000 after buying an additional 2,768 shares during the last quarter. Algert Global LLC bought a new position in LifeStance Health Group during the 2nd quarter valued at about $57,000. Victory Capital Management Inc. grew its stake in shares of LifeStance Health Group by 27.0% in the second quarter. Victory Capital Management Inc. now owns 14,407 shares of the company's stock worth $71,000 after acquiring an additional 3,063 shares during the period. Finally, Park Edge Advisors LLC bought a new position in shares of LifeStance Health Group during the 3rd quarter valued at $73,000. 85.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total transaction of $33,089.32. Following the completion of the transaction, the insider now owns 263,007 shares of the company's stock, valued at approximately $1,651,683.96. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 6.60% of the stock is owned by company insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.